EX-99.1 2 a07-20757_1ex99d1.htm EX-99.1

Exhibit 99.1

Company Contact:

Investor Contact:

Agency Contact:

David Snyder

Stephen Bassett

Heather Smith

Axcelis Technologies, Inc.

Axcelis Technologies, Inc.

Loomis Group

Tel: +1 (978) 787 4273

Tel: +1 (978) 787 4000

Tel: +1 (617) 309 8005

Fax: +1 (978) 787 4275

Fax: +1 (978) 787 9133

Fax: +1 (617) 638 0033

david.snyder@axcelis.com

investor.relations@axcelis.com

smithh@loomisgroup.com

 

AXCELIS ANNOUNCES FINANCIAL RESULTS
FOR SECOND QUARTER 2007

BEVERLY, Mass. — August 1, 2007 — Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter ended June 30, 2007. The Company reported revenues of $110.1 million, compared to $97.5 million for the first quarter of 2007. Net income for the second quarter was $4.7 million, or $0.05 per share, compared to net income for the first quarter of 2007 of $2.7 million, or $0.03 per share. In the corresponding quarter for the previous year, the Company reported revenues of $117.6 million and net income of $12.1 million, or $0.12 per share.

Commenting on the Company’s performance, Chairman and CEO Mary Puma said, “We continue to receive positive feedback from customers on advanced technology development and production manufacturing being run on our Optima HD, despite the softening industry conditions. We are confident that continued progress will drive growth of our high dose implant business as we secure additional orders through design wins and capacity buys. Additionally, we were able to win another high volume capacity order for our dry strip products, strengthening our position in the cleaning space.  We look forward to this trend continuing.”

Second Quarter Detail

Shipments and Margins

Shipments before provision for deferred revenue for the second quarter totaled $116.3 million. Geographically, Axcelis’ systems shipments for the quarter were to: Asia, 59%; North America, 29%; and Europe; 12%. The ion implantation business accounted for 76% of total shipments in the second quarter, while other products (dry strip, curing, and RTP) accounted for 24%. Gross margin for the second quarter was 39.6%.

Orders and Backlog

Orders (new systems bookings and service) received for the second quarter totaled $75.8 million. New systems bookings, excluding service, amounted to $34.5 million. Backlog plus deferred systems revenue at quarter end was $93.4 million. Backlog consists of systems only (i.e., excluding service contracts) that are generally scheduled to ship within six months.




SEN Corporation, an SHI and Axcelis Company (“SEN”)

Axcelis owns 50% of SEN, a Japanese company that is licensed to make and sell certain Axcelis ion implanters in Japan. SEN’s revenue for the second quarter totaled $55.2 million.

Business Outlook

Axcelis’ financial outlook for the third quarter of 2007 includes revenues in the range of $110 million to $120 million. Gross margins in the third quarter are expected to be slightly below second quarter levels as a result of revenue recognition on new products. The Company forecasts third quarter earnings per share of approximately $0.02. Axcelis assumes no responsibility to update guidance. Axcelis will only confirm or update guidance via a press release.

Second Quarter 2007 Conference Call

The Company will be hosting a conference call today, Wednesday, August 1, 2007, beginning at 5:00 pm ET. The purpose of the call is to discuss second quarter results and to provide guidance for the third quarter of 2007.

The call will be available to interested listeners via an audio webcast that can be accessed through Axcelis’ home page at www.axcelis.com, or by dialing 1-800-479-1628 (1-719-457-2729 outside North America).  Participants calling into the conference call will be requested to provide the company name: Axcelis Technologies, the conference leader: David Snyder, and pass code: #1476171.  A webcast replay will be available from 8:00 pm ET on August 1, 2007 until 5:00 pm ET September 1, 2007.

Safe Harbor Statement

This document contains forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, our ability to implement successfully our profit plans, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

About Axcelis Technologies, Inc.

Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, rapid thermal processing, and cleaning and curing systems. Axcelis also licenses its 50% owned joint venture, SEN Corporation, an SHI and Axcelis Company, to manufacture and sell certain implant products in Japan. The company’s Internet address is: www.axcelis.com.




Axcelis Technologies, Inc.
Consolidated Balance Sheets
In thousands
(Unaudited)

 

 

June 30,
2007

 

December 31,
2006

 

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

63,782

 

$

140,451

 

Marketable securities

 

18,000

 

63,200

 

Restricted cash

 

15,168

 

11,019

 

Accounts receivable, net

 

79,696

 

73,635

 

Inventories, net

 

175,939

 

160,107

 

Prepaid expenses and other current assets

 

36,621

 

26,639

 

Total current assets

 

389,206

 

475,051

 

 

 

 

 

 

 

Property, plant & equipment, net

 

68,468

 

66,678

 

Investment in SEN

 

123,295

 

126,688

 

Goodwill

 

46,773

 

46,773

 

Intangible assets

 

12,237

 

13,549

 

Restricted cash, long-term portion

 

 

1,137

 

Other assets

 

30,940

 

24,117

 

 

 

$

670,919

 

$

753,993

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

24,684

 

$

37,312

 

Accrued compensation

 

15,731

 

26,996

 

Warranty

 

5,567

 

5,229

 

Income taxes

 

817

 

3,906

 

Deferred revenue

 

40,642

 

28,811

 

Other current liabilities

 

8,614

 

13,670

 

Current portion, convertible subordinated debt

 

 

74,217

 

Total current liabilities

 

96,055

 

190,141

 

 

 

 

 

 

 

Convertible subordinated debt

 

78,375

 

76,887

 

Long-term deferred revenue

 

2,905

 

5,054

 

Other long-term liabilities

 

6,881

 

4,349

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred Stock

 

 

 

Common stock

 

102

 

101

 

Additional paid-in capital

 

475,514

 

469,967

 

Treasury stock

 

(1,218

)

(1,218

)

Retained earnings

 

17,000

 

9,583

 

Accumulated other comprehensive loss

 

(4,695

)

(871

)

 

 

486,703

 

477,562

 

 

 

$

670,919

 

$

753,993

 

 




 

Axcelis Technologies, Inc.
Consolidated Statements of Income
In thousands, except per share amounts
(Unaudited)

 

 

Three months ended
June 30,

 

Six months ended
June 30,

 

 

 

2007

 

2006

 

2007

 

2006

 

Revenue

 

 

 

 

 

 

 

 

 

Systems

 

$

67,361

 

$

67,734

 

$

118,425

 

$

120,138

 

Services

 

41,272

 

46,863

 

85,674

 

90,944

 

Royalties, primarily from SEN

 

1,440

 

3,043

 

3,500

 

4,479

 

 

 

110,073

 

117,640

 

207,599

 

215,561

 

Cost of revenue

 

66,483

 

69,698

 

122,759

 

128,577

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

43,590

 

47,942

 

84,840

 

86,984

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research & development

 

17,598

 

18,191

 

35,826

 

36,403

 

Sales and marketing

 

13,146

 

11,569

 

26,084

 

22,176

 

General and administrative

 

10,194

 

11,419

 

20,670

 

22,272

 

Amortization of intangible assets

 

656

 

627

 

1,312

 

1,239

 

Restructuring charges

 

 

399

 

 

94

 

 

 

41,594

 

42,205

 

83,892

 

82,184

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

1,996

 

5,737

 

948

 

4,800

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Equity income of SEN

 

1,905

 

6,146

 

6,573

 

8,362

 

Interest income

 

1,146

 

1,915

 

2,600

 

3,566

 

Interest expense

 

(1,566

)

(2,446

)

(3,235

)

(4,087

)

Other-net

 

275

 

1,339

 

251

 

684

 

 

 

1,760

 

6,954

 

6,189

 

8,525

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

3,756

 

12,691

 

7,137

 

13,325

 

 

 

 

 

 

 

 

 

 

 

Income taxes (credits)

 

(988

)

547

 

(280

)

636

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

4,744

 

$

12,144

 

$

7,417

 

$

12,689

 

 

 

 

 

 

 

 

 

 

 

Net income per share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.05

 

$

0.12

 

$

0.07

 

$

0.13

 

Diluted

 

$

0.05

 

$

0.12

 

$

0.07

 

$

0.13

 

 

 

 

 

 

 

 

 

 

 

Shares used in computing net income per share

 

 

 

 

 

 

 

 

 

Basic

 

101,609

 

100,958

 

101,551

 

100,921

 

Diluted

 

102,503

 

101,080

 

102,463

 

101,098